Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Case Report: Wound Care of a Diabetic Foot Ulcer

Author(s):  Wynn Tom

Issue:  Jul/Aug 2004 - Wound Care
View All Articles in Issue

Page(s):  265-267

Case Report:  Wound Care of a Diabetic Foot Ulcer Page 1
Case Report:  Wound Care of a Diabetic Foot Ulcer Page 2
Case Report:  Wound Care of a Diabetic Foot Ulcer Page 3

Download in electronic PDF format for $65

Abstract:  Wound care is one of the main concerns of patients with diabetes. This case involves a 65-year-old woman with a wound (4 cm x 2 cm) on her right foot, underneath the big toe. The patient had not been successful in healing this wound using conventional preparations for a year. A decision was made to compound a wound-care gel formulation, and two preparations were compounded. One contained phenytoin 3% and misoprostol 0.0024% gel and was used for wound healing. The patient was instructed to cover the wound twice daily with about 0.2 mL of this preparation. The other preparation was nifedipine 10% in a Pluronic lecithin organogel 20%. The patient was instructed to apply 0.6 mL twice daily around the wound and callous surrounding the wound and up the foot to increase circulation to the wound area. Saline rinses, which the patient had already been using, were continued as before (with application of the nifedipine gel afterward, followed by application of the phenytoin/misoprostol formulation). The wound was covered with sterile gauze. Healing was seen almost immediately and was quite advanced after 8 weeks. During 4 additional weeks, final closure of the wound occurred. Total healing time for the wound was 17 weeks. The author concludes that wound gels are effective in healing diabetic foot ulcers and that this is a promising therapeutic alternative for patients with refractory foot ulcers.

Related Keywords: Diabetic foot ulcer, compounding for, Metronidazole, compounded for diabetic foot ulcer, Misoprostol, compounded for diabetic foot ulcer, Nifedipine, compounded for diabetic foot ulcer, Phenytoin, compounded for diabetic foot ulcer, Thompson, Chad, PharmD, Ulcer, diabetic foot, compounding for, Wound care, of diabetic foot ulcer, compounding for, Wynn, Tom, RPh

Related Categories: DIABETES, GERIATRICS, WOUND CARE, CASE REPORTS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186

Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
Jan/Feb 2003
Pg. 21-23

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
Mar/Apr 2000
Pg. 94-96

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert
, Harshbarger Diana
Mar/Apr 2000
Pg. 84-87

Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream
Meece Jerry
May/Jun 2003
Pg. 171

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions